Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis Risk

The U.S. Food and Drug Administration (FDA) revised the boxed warning for Metformin Hydrochloride on 2026-07-28. This revision highlights the serious and potentially fatal risk of lactic acidosis associated with the drug. The updated warning emphasizes that postmarketing cases of metformin-associated lactic acidosis have resulted in severe outcomes, including death, hypothermia, hypotension, and resistant bradyarrhythmias.

Background

The revised boxed warning for Metformin Hydrochloride specifically addresses lactic acidosis, a rare but serious metabolic complication that can occur due to metformin accumulation. This warning is a critical component of the drug's safety information, alerting prescribers and patients to the potential for severe adverse events. The update underscores that the onset of metformin-associated lactic acidosis is often subtle, making early recognition challenging yet crucial. The warning details that postmarketing cases have shown this condition can lead to significant clinical deterioration, including hypotension and resistant bradyarrhythmias, in addition to the risk of death.

What this means

The revision to the boxed warning for Metformin Hydrochloride serves as a critical update for healthcare professionals. It reinforces the necessity for vigilance in identifying the signs and symptoms of lactic acidosis, particularly given its often subtle onset. Clinicians should be aware that postmarketing cases have demonstrated severe clinical manifestations, including death, hypothermia, hypotension, and resistant bradyarrhythmias. This updated guidance emphasizes the importance of patient education regarding symptoms of lactic acidosis and the need for immediate medical attention if they occur, thereby aiming to mitigate the risks associated with this serious adverse event.

Source

This information was sourced from the U.S. Food and Drug Administration (FDA), detailing a label revision for Metformin Hydrochloride effective 2026-07-28. The full details of the revised boxed warning are available on dailymed.nlm.nih.gov, specifically within the DailyMed entry identified by setid=1503bbe4-0ac5-479b-9900-d38e49236bf0.